Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) EPS (Weighted Average and Diluted) (2020 - 2025)

GoHealth's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$13.42 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 3017.39% year-over-year to -$13.42; the TTM value through Sep 2025 reached -$16.66, down 385.71%, while the annual FY2024 figure was -$0.66, 90.82% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$13.42 at GoHealth, down from -$5.2 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.48 in Q4 2024 and bottomed at -$26.47 in Q4 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$1.74 (2022), against an average of -$4.28.
  • The largest annual shift saw EPS (Weighted Average and Diluted) crashed 8600.0% in 2022 before it skyrocketed 1753.33% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$26.47 in 2021, then surged by 35.7% to -$17.02 in 2022, then surged by 99.12% to -$0.15 in 2023, then surged by 1753.33% to $2.48 in 2024, then tumbled by 641.13% to -$13.42 in 2025.
  • Per Business Quant, the three most recent readings for GOCO's EPS (Weighted Average and Diluted) are -$13.42 (Q3 2025), -$5.2 (Q2 2025), and -$0.52 (Q1 2025).